4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155969
Options or other derivatives
- Chief Operating Officer acquired 72,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Powala Christopher · Chief Operating Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-12-15 | Grant or award : show line 1 in the form Stock option (right to buy) | +62,400 | 62,400 | D |
| 2016-12-15 | Grant or award : show line 2 in the form Restricted stock units | +10,400 | 10,400 | D |
Loading xslF345X03/doc4.xml…